A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
NCT: NCT06935266 · COMPLETED
Brief Summary
The main aim of this study is to check how well healthy adults can tolerate TAK-881 with different dosing schedules. During the study, participants will receive one infusion of TAK-881 under the skin (subcutaneous \[SC\] infusion) on Day 1 at a lower dose level followed by participants receiving multiple infusion of higher dose levels. Participants will be in the study for approximately 19 weeks including screening period and follow-up (End of Treatment \[EOT\]).
Frequently Asked Questions
What is A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults?
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults is a clinical trial registered under NCT06935266. Current status: COMPLETED.
What is the status of NCT06935266?
The current status of NCT06935266 (A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults) is: COMPLETED.
When did A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults start?
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults started on 2025-04-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.